IRIDEX Corp
IRIX1.000USD
+0.030+3.09%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
17.05MMarket Cap
LossP/E TTM
More Details of IRIDEX Corp Company
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
IRIDEX Corp Info
Ticker SymbolIRIX
Company nameIRIDEX Corp
IPO dateFeb 16, 1996
CEOMercer (Patrick)
Number of employees93
Security typeOrdinary Share
Fiscal year-endFeb 16
Address1212 Terra Bella Ave
CityMOUNTAIN VIEW
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94043
Phone16509404700
Websitehttps://www.iridex.com/
Ticker SymbolIRIX
IPO dateFeb 16, 1996
CEOMercer (Patrick)
Company Executives of IRIDEX Corp
Name
Name/Position
Position
Shareholding
Change
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
350.00K
+16.67%
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
100.14K
-19.23%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
96.92K
+1.66%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
+237.21%
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
89.99K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
350.00K
+16.67%
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
100.14K
-19.23%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
96.92K
+1.66%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
+237.21%
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
89.99K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Retina
8.05M
59.30%
G6
3.29M
24.27%
Other
2.23M
16.43%
By RegionUSD
Name
Revenue
Proportion
United States
5.76M
42.44%
Asia/Pacific Rim
3.67M
27.08%
Europe & Middle East & Africa
3.65M
26.92%
Rest of the Americas
483.00K
3.56%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Retina
8.05M
59.30%
G6
3.29M
24.27%
Other
2.23M
16.43%
Shareholding Stats
Updated: Sat, Nov 22
Updated: Sat, Nov 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Topcon Corp
9.41%
Stanley Manne Trust
6.24%
Paragon JV Partners, LLC
5.82%
The Vanguard Group, Inc.
3.37%
Roland (Brent Alexander)
2.69%
Other
72.48%
Shareholders
Shareholders
Proportion
Topcon Corp
9.41%
Stanley Manne Trust
6.24%
Paragon JV Partners, LLC
5.82%
The Vanguard Group, Inc.
3.37%
Roland (Brent Alexander)
2.69%
Other
72.48%
Shareholder Types
Shareholders
Proportion
Corporation
17.71%
Individual Investor
10.65%
Hedge Fund
9.90%
Investment Advisor
4.70%
Investment Advisor/Hedge Fund
1.34%
Research Firm
0.39%
Venture Capital
0.15%
Other
55.15%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
46
2.61M
15.39%
-533.70K
2025Q2
62
7.58M
45.15%
+346.62K
2025Q1
57
6.59M
39.89%
-547.85K
2024Q4
56
6.67M
40.12%
-576.91K
2024Q3
56
6.58M
39.55%
-791.78K
2024Q2
63
7.41M
45.29%
-103.92K
2024Q1
64
7.34M
45.55%
+258.49K
2023Q4
68
7.28M
45.21%
-25.53K
2023Q3
68
7.58M
47.03%
+345.93K
2023Q2
71
7.91M
49.44%
+523.96K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Topcon Corp
1.62M
9.52%
+6.00K
+0.37%
Apr 01, 2025
Stanley Manne Trust
1.07M
6.31%
--
--
Apr 01, 2025
Paragon JV Partners, LLC
1.00M
5.88%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
585.81K
3.45%
-8.97K
-1.51%
Jun 30, 2025
Roland (Brent Alexander)
461.71K
2.72%
+461.71K
--
Apr 01, 2025
Moore (William M)
300.00K
1.77%
+12.02K
+4.18%
Aug 18, 2025
Renaissance Technologies LLC
378.76K
2.23%
-400.00
-0.11%
Jun 30, 2025
Roland Family Support Trust
223.69K
1.32%
+223.69K
--
Apr 01, 2025
AMH Equity, Ltd.
190.00K
1.12%
-328.54K
-63.36%
Jun 30, 2025
Roland (Glenn Cuthbert)
181.60K
1.07%
+181.60K
--
Apr 01, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of IRIDEX Corp?
The top five shareholders of IRIDEX Corp are:
Topcon Corp holds 1.62M shares, accounting for 9.52% of the total shares.
Stanley Manne Trust holds 1.07M shares, accounting for 6.31% of the total shares.
Paragon JV Partners, LLC holds 1.00M shares, accounting for 5.88% of the total shares.
The Vanguard Group, Inc. holds 585.81K shares, accounting for 3.45% of the total shares.
Roland (Brent Alexander) holds 461.71K shares, accounting for 2.72% of the total shares.
Topcon Corp holds 1.62M shares, accounting for 9.52% of the total shares.
Stanley Manne Trust holds 1.07M shares, accounting for 6.31% of the total shares.
Paragon JV Partners, LLC holds 1.00M shares, accounting for 5.88% of the total shares.
The Vanguard Group, Inc. holds 585.81K shares, accounting for 3.45% of the total shares.
Roland (Brent Alexander) holds 461.71K shares, accounting for 2.72% of the total shares.
What are the top three shareholder types of IRIDEX Corp?
The top three shareholder types of IRIDEX Corp are:
Topcon Corp
Stanley Manne Trust
Paragon JV Partners, LLC
Topcon Corp
Stanley Manne Trust
Paragon JV Partners, LLC
How many institutions hold shares of IRIDEX Corp (IRIX)?
As of 2025Q3, 46 institutions hold shares of IRIDEX Corp, with a combined market value of approximately 2.61M, accounting for 15.39% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -29.77%.
What is the biggest source of revenue for IRIDEX Corp?
In FY2025Q2, the Retina business generated the highest revenue for IRIDEX Corp, amounting to 8.05M and accounting for 59.30% of total revenue.
